nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP3A4—Thiotepa—sarcoma	0.106	0.405	CbGbCtD
Bicalutamide—CYP3A4—Mitoxantrone—sarcoma	0.0455	0.174	CbGbCtD
Bicalutamide—CYP3A4—Vincristine—sarcoma	0.0313	0.12	CbGbCtD
Bicalutamide—CYP2D6—Doxorubicin—sarcoma	0.0308	0.118	CbGbCtD
Bicalutamide—CYP3A4—Etoposide—sarcoma	0.0287	0.11	CbGbCtD
Bicalutamide—CYP3A4—Doxorubicin—sarcoma	0.0196	0.0748	CbGbCtD
Bicalutamide—AR—scrotum—sarcoma	0.0162	0.421	CbGeAlD
Bicalutamide—CYP2C9—mammary gland—sarcoma	0.00165	0.043	CbGeAlD
Bicalutamide—AR—myometrium—sarcoma	0.00163	0.0424	CbGeAlD
Bicalutamide—AR—seminal vesicle—sarcoma	0.00147	0.0383	CbGeAlD
Bicalutamide—AR—hematopoietic system—sarcoma	0.0014	0.0364	CbGeAlD
Bicalutamide—AR—connective tissue—sarcoma	0.00135	0.0351	CbGeAlD
Bicalutamide—CYP2C19—hematopoietic system—sarcoma	0.0013	0.0338	CbGeAlD
Bicalutamide—AR—smooth muscle tissue—sarcoma	0.00123	0.0321	CbGeAlD
Bicalutamide—AR—skin of body—sarcoma	0.00122	0.0317	CbGeAlD
Bicalutamide—AR—cardiac atrium—sarcoma	0.00106	0.0277	CbGeAlD
Bicalutamide—AR—uterus—sarcoma	0.00106	0.0275	CbGeAlD
Bicalutamide—CYP2C9—hematopoietic system—sarcoma	0.00101	0.0262	CbGeAlD
Bicalutamide—AR—lymphoid tissue—sarcoma	0.000985	0.0257	CbGeAlD
Bicalutamide—AR—tendon—sarcoma	0.000926	0.0241	CbGeAlD
Bicalutamide—AR—testis—sarcoma	0.000767	0.02	CbGeAlD
Bicalutamide—CYP3A4—hematopoietic system—sarcoma	0.000767	0.02	CbGeAlD
Bicalutamide—CYP2D6—hematopoietic system—sarcoma	0.000754	0.0196	CbGeAlD
Bicalutamide—AR—liver—sarcoma	0.000725	0.0189	CbGeAlD
Bicalutamide—Influenza—Epirubicin—sarcoma	0.000716	0.00102	CcSEcCtD
Bicalutamide—Asthma—Epirubicin—sarcoma	0.000716	0.00102	CcSEcCtD
Bicalutamide—Dysphagia—Epirubicin—sarcoma	0.000716	0.00102	CcSEcCtD
Bicalutamide—Pruritus—Thiotepa—sarcoma	0.000715	0.00102	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000714	0.00102	CcSEcCtD
Bicalutamide—Dehydration—Doxorubicin—sarcoma	0.000713	0.00102	CcSEcCtD
Bicalutamide—Thrombocytopenia—Etoposide—sarcoma	0.000711	0.00102	CcSEcCtD
Bicalutamide—Eosinophilia—Epirubicin—sarcoma	0.000709	0.00101	CcSEcCtD
Bicalutamide—Abdominal pain—Vincristine—sarcoma	0.000709	0.00101	CcSEcCtD
Bicalutamide—Body temperature increased—Vincristine—sarcoma	0.000709	0.00101	CcSEcCtD
Bicalutamide—Liver function test abnormal—Doxorubicin—sarcoma	0.000707	0.00101	CcSEcCtD
Bicalutamide—Skin disorder—Etoposide—sarcoma	0.000705	0.00101	CcSEcCtD
Bicalutamide—Dry skin—Doxorubicin—sarcoma	0.000702	0.001	CcSEcCtD
Bicalutamide—Hyperhidrosis—Etoposide—sarcoma	0.000702	0.001	CcSEcCtD
Bicalutamide—Angina pectoris—Epirubicin—sarcoma	0.000697	0.000996	CcSEcCtD
Bicalutamide—Urticaria—Mitoxantrone—sarcoma	0.000694	0.000991	CcSEcCtD
Bicalutamide—Breast disorder—Doxorubicin—sarcoma	0.000692	0.000989	CcSEcCtD
Bicalutamide—Anorexia—Etoposide—sarcoma	0.000692	0.000989	CcSEcCtD
Bicalutamide—Diarrhoea—Thiotepa—sarcoma	0.000692	0.000988	CcSEcCtD
Bicalutamide—Body temperature increased—Mitoxantrone—sarcoma	0.00069	0.000986	CcSEcCtD
Bicalutamide—Abdominal pain—Mitoxantrone—sarcoma	0.00069	0.000986	CcSEcCtD
Bicalutamide—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00069	0.000986	CcSEcCtD
Bicalutamide—Bronchitis—Epirubicin—sarcoma	0.000688	0.000984	CcSEcCtD
Bicalutamide—Diarrhoea—Dactinomycin—sarcoma	0.000686	0.000981	CcSEcCtD
Bicalutamide—Gastritis—Doxorubicin—sarcoma	0.000678	0.000969	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000676	0.000966	CcSEcCtD
Bicalutamide—Muscular weakness—Doxorubicin—sarcoma	0.000676	0.000966	CcSEcCtD
Bicalutamide—CYP2C19—liver—sarcoma	0.000672	0.0175	CbGeAlD
Bicalutamide—Dysuria—Epirubicin—sarcoma	0.000669	0.000956	CcSEcCtD
Bicalutamide—Neutropenia—Epirubicin—sarcoma	0.000669	0.000956	CcSEcCtD
Bicalutamide—Dizziness—Thiotepa—sarcoma	0.000668	0.000955	CcSEcCtD
Bicalutamide—Asthma—Doxorubicin—sarcoma	0.000662	0.000946	CcSEcCtD
Bicalutamide—Influenza—Doxorubicin—sarcoma	0.000662	0.000946	CcSEcCtD
Bicalutamide—Dysphagia—Doxorubicin—sarcoma	0.000662	0.000946	CcSEcCtD
Bicalutamide—Pollakiuria—Epirubicin—sarcoma	0.000661	0.000945	CcSEcCtD
Bicalutamide—Hypersensitivity—Vincristine—sarcoma	0.00066	0.000944	CcSEcCtD
Bicalutamide—Eosinophilia—Doxorubicin—sarcoma	0.000656	0.000937	CcSEcCtD
Bicalutamide—Paraesthesia—Etoposide—sarcoma	0.000652	0.000932	CcSEcCtD
Bicalutamide—Weight increased—Epirubicin—sarcoma	0.000651	0.000931	CcSEcCtD
Bicalutamide—Weight decreased—Epirubicin—sarcoma	0.000648	0.000925	CcSEcCtD
Bicalutamide—Dyspnoea—Etoposide—sarcoma	0.000647	0.000925	CcSEcCtD
Bicalutamide—Hyperglycaemia—Epirubicin—sarcoma	0.000646	0.000923	CcSEcCtD
Bicalutamide—Somnolence—Etoposide—sarcoma	0.000646	0.000922	CcSEcCtD
Bicalutamide—Angina pectoris—Doxorubicin—sarcoma	0.000645	0.000922	CcSEcCtD
Bicalutamide—Hypersensitivity—Mitoxantrone—sarcoma	0.000643	0.000919	CcSEcCtD
Bicalutamide—Asthenia—Vincristine—sarcoma	0.000643	0.000919	CcSEcCtD
Bicalutamide—Vomiting—Thiotepa—sarcoma	0.000643	0.000918	CcSEcCtD
Bicalutamide—Pneumonia—Epirubicin—sarcoma	0.000642	0.000917	CcSEcCtD
Bicalutamide—Vomiting—Dactinomycin—sarcoma	0.000638	0.000911	CcSEcCtD
Bicalutamide—Rash—Thiotepa—sarcoma	0.000637	0.000911	CcSEcCtD
Bicalutamide—Bronchitis—Doxorubicin—sarcoma	0.000637	0.00091	CcSEcCtD
Bicalutamide—Dermatitis—Thiotepa—sarcoma	0.000637	0.00091	CcSEcCtD
Bicalutamide—Headache—Thiotepa—sarcoma	0.000633	0.000905	CcSEcCtD
Bicalutamide—Rash—Dactinomycin—sarcoma	0.000633	0.000904	CcSEcCtD
Bicalutamide—Decreased appetite—Etoposide—sarcoma	0.000631	0.000902	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Etoposide—sarcoma	0.000627	0.000896	CcSEcCtD
Bicalutamide—Asthenia—Mitoxantrone—sarcoma	0.000626	0.000895	CcSEcCtD
Bicalutamide—Fatigue—Etoposide—sarcoma	0.000626	0.000895	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Epirubicin—sarcoma	0.000626	0.000894	CcSEcCtD
Bicalutamide—Jaundice—Epirubicin—sarcoma	0.000622	0.000889	CcSEcCtD
Bicalutamide—Pain—Etoposide—sarcoma	0.000621	0.000887	CcSEcCtD
Bicalutamide—Constipation—Etoposide—sarcoma	0.000621	0.000887	CcSEcCtD
Bicalutamide—Urinary tract infection—Epirubicin—sarcoma	0.00062	0.000886	CcSEcCtD
Bicalutamide—Conjunctivitis—Epirubicin—sarcoma	0.00062	0.000886	CcSEcCtD
Bicalutamide—Dysuria—Doxorubicin—sarcoma	0.000619	0.000885	CcSEcCtD
Bicalutamide—Neutropenia—Doxorubicin—sarcoma	0.000619	0.000885	CcSEcCtD
Bicalutamide—Diarrhoea—Vincristine—sarcoma	0.000613	0.000876	CcSEcCtD
Bicalutamide—Sweating—Epirubicin—sarcoma	0.000612	0.000874	CcSEcCtD
Bicalutamide—Pollakiuria—Doxorubicin—sarcoma	0.000612	0.000874	CcSEcCtD
Bicalutamide—Haematuria—Epirubicin—sarcoma	0.000608	0.000869	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Epirubicin—sarcoma	0.000604	0.000862	CcSEcCtD
Bicalutamide—Weight increased—Doxorubicin—sarcoma	0.000603	0.000861	CcSEcCtD
Bicalutamide—Epistaxis—Epirubicin—sarcoma	0.000602	0.00086	CcSEcCtD
Bicalutamide—Nausea—Thiotepa—sarcoma	0.0006	0.000858	CcSEcCtD
Bicalutamide—Weight decreased—Doxorubicin—sarcoma	0.000599	0.000856	CcSEcCtD
Bicalutamide—Sinusitis—Epirubicin—sarcoma	0.000599	0.000856	CcSEcCtD
Bicalutamide—Feeling abnormal—Etoposide—sarcoma	0.000598	0.000855	CcSEcCtD
Bicalutamide—Hyperglycaemia—Doxorubicin—sarcoma	0.000597	0.000854	CcSEcCtD
Bicalutamide—Diarrhoea—Mitoxantrone—sarcoma	0.000597	0.000853	CcSEcCtD
Bicalutamide—Nausea—Dactinomycin—sarcoma	0.000596	0.000852	CcSEcCtD
Bicalutamide—Pneumonia—Doxorubicin—sarcoma	0.000594	0.000849	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Etoposide—sarcoma	0.000594	0.000848	CcSEcCtD
Bicalutamide—Dizziness—Vincristine—sarcoma	0.000593	0.000847	CcSEcCtD
Bicalutamide—Bradycardia—Epirubicin—sarcoma	0.000583	0.000833	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Doxorubicin—sarcoma	0.000579	0.000827	CcSEcCtD
Bicalutamide—Urticaria—Etoposide—sarcoma	0.000577	0.000824	CcSEcCtD
Bicalutamide—Haemoglobin—Epirubicin—sarcoma	0.000576	0.000823	CcSEcCtD
Bicalutamide—Jaundice—Doxorubicin—sarcoma	0.000576	0.000822	CcSEcCtD
Bicalutamide—Rhinitis—Epirubicin—sarcoma	0.000574	0.000821	CcSEcCtD
Bicalutamide—Abdominal pain—Etoposide—sarcoma	0.000574	0.00082	CcSEcCtD
Bicalutamide—Body temperature increased—Etoposide—sarcoma	0.000574	0.00082	CcSEcCtD
Bicalutamide—Urinary tract infection—Doxorubicin—sarcoma	0.000574	0.00082	CcSEcCtD
Bicalutamide—Conjunctivitis—Doxorubicin—sarcoma	0.000574	0.00082	CcSEcCtD
Bicalutamide—Haemorrhage—Epirubicin—sarcoma	0.000573	0.000819	CcSEcCtD
Bicalutamide—Vomiting—Vincristine—sarcoma	0.00057	0.000814	CcSEcCtD
Bicalutamide—Pharyngitis—Epirubicin—sarcoma	0.000569	0.000812	CcSEcCtD
Bicalutamide—Sweating—Doxorubicin—sarcoma	0.000566	0.000809	CcSEcCtD
Bicalutamide—Urinary tract disorder—Epirubicin—sarcoma	0.000566	0.000808	CcSEcCtD
Bicalutamide—Rash—Vincristine—sarcoma	0.000565	0.000808	CcSEcCtD
Bicalutamide—Dermatitis—Vincristine—sarcoma	0.000565	0.000807	CcSEcCtD
Bicalutamide—Oedema peripheral—Epirubicin—sarcoma	0.000564	0.000806	CcSEcCtD
Bicalutamide—Haematuria—Doxorubicin—sarcoma	0.000563	0.000804	CcSEcCtD
Bicalutamide—Urethral disorder—Epirubicin—sarcoma	0.000562	0.000802	CcSEcCtD
Bicalutamide—Headache—Vincristine—sarcoma	0.000562	0.000802	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Doxorubicin—sarcoma	0.000558	0.000798	CcSEcCtD
Bicalutamide—Epistaxis—Doxorubicin—sarcoma	0.000557	0.000796	CcSEcCtD
Bicalutamide—AR—lymph node—sarcoma	0.000556	0.0145	CbGeAlD
Bicalutamide—Vomiting—Mitoxantrone—sarcoma	0.000555	0.000793	CcSEcCtD
Bicalutamide—Sinusitis—Doxorubicin—sarcoma	0.000554	0.000792	CcSEcCtD
Bicalutamide—Visual impairment—Epirubicin—sarcoma	0.000552	0.000789	CcSEcCtD
Bicalutamide—Rash—Mitoxantrone—sarcoma	0.00055	0.000786	CcSEcCtD
Bicalutamide—Dermatitis—Mitoxantrone—sarcoma	0.00055	0.000786	CcSEcCtD
Bicalutamide—Headache—Mitoxantrone—sarcoma	0.000547	0.000781	CcSEcCtD
Bicalutamide—Bradycardia—Doxorubicin—sarcoma	0.00054	0.000771	CcSEcCtD
Bicalutamide—Hypersensitivity—Etoposide—sarcoma	0.000535	0.000764	CcSEcCtD
Bicalutamide—Haemoglobin—Doxorubicin—sarcoma	0.000533	0.000761	CcSEcCtD
Bicalutamide—Nausea—Vincristine—sarcoma	0.000532	0.000761	CcSEcCtD
Bicalutamide—Cardiac disorder—Epirubicin—sarcoma	0.000532	0.00076	CcSEcCtD
Bicalutamide—Rhinitis—Doxorubicin—sarcoma	0.000531	0.000759	CcSEcCtD
Bicalutamide—Haemorrhage—Doxorubicin—sarcoma	0.00053	0.000757	CcSEcCtD
Bicalutamide—Pharyngitis—Doxorubicin—sarcoma	0.000526	0.000752	CcSEcCtD
Bicalutamide—Urinary tract disorder—Doxorubicin—sarcoma	0.000524	0.000748	CcSEcCtD
Bicalutamide—Oedema peripheral—Doxorubicin—sarcoma	0.000522	0.000746	CcSEcCtD
Bicalutamide—Asthenia—Etoposide—sarcoma	0.000521	0.000744	CcSEcCtD
Bicalutamide—CYP2C9—liver—sarcoma	0.000521	0.0136	CbGeAlD
Bicalutamide—Angiopathy—Epirubicin—sarcoma	0.00052	0.000743	CcSEcCtD
Bicalutamide—Urethral disorder—Doxorubicin—sarcoma	0.00052	0.000742	CcSEcCtD
Bicalutamide—Nausea—Mitoxantrone—sarcoma	0.000519	0.000741	CcSEcCtD
Bicalutamide—Immune system disorder—Epirubicin—sarcoma	0.000517	0.000739	CcSEcCtD
Bicalutamide—Mediastinal disorder—Epirubicin—sarcoma	0.000516	0.000738	CcSEcCtD
Bicalutamide—Chills—Epirubicin—sarcoma	0.000514	0.000735	CcSEcCtD
Bicalutamide—Pruritus—Etoposide—sarcoma	0.000514	0.000734	CcSEcCtD
Bicalutamide—Arrhythmia—Epirubicin—sarcoma	0.000512	0.000731	CcSEcCtD
Bicalutamide—Visual impairment—Doxorubicin—sarcoma	0.000511	0.00073	CcSEcCtD
Bicalutamide—Alopecia—Epirubicin—sarcoma	0.000506	0.000723	CcSEcCtD
Bicalutamide—Mental disorder—Epirubicin—sarcoma	0.000502	0.000717	CcSEcCtD
Bicalutamide—Malnutrition—Epirubicin—sarcoma	0.000499	0.000713	CcSEcCtD
Bicalutamide—Diarrhoea—Etoposide—sarcoma	0.000497	0.00071	CcSEcCtD
Bicalutamide—Cardiac disorder—Doxorubicin—sarcoma	0.000492	0.000703	CcSEcCtD
Bicalutamide—Flatulence—Epirubicin—sarcoma	0.000491	0.000702	CcSEcCtD
Bicalutamide—Tension—Epirubicin—sarcoma	0.000489	0.000699	CcSEcCtD
Bicalutamide—Nervousness—Epirubicin—sarcoma	0.000484	0.000692	CcSEcCtD
Bicalutamide—Back pain—Epirubicin—sarcoma	0.000482	0.000689	CcSEcCtD
Bicalutamide—Angiopathy—Doxorubicin—sarcoma	0.000481	0.000687	CcSEcCtD
Bicalutamide—Dizziness—Etoposide—sarcoma	0.00048	0.000686	CcSEcCtD
Bicalutamide—Muscle spasms—Epirubicin—sarcoma	0.000479	0.000685	CcSEcCtD
Bicalutamide—Immune system disorder—Doxorubicin—sarcoma	0.000479	0.000684	CcSEcCtD
Bicalutamide—Mediastinal disorder—Doxorubicin—sarcoma	0.000478	0.000683	CcSEcCtD
Bicalutamide—Chills—Doxorubicin—sarcoma	0.000476	0.00068	CcSEcCtD
Bicalutamide—Arrhythmia—Doxorubicin—sarcoma	0.000474	0.000677	CcSEcCtD
Bicalutamide—Alopecia—Doxorubicin—sarcoma	0.000468	0.000669	CcSEcCtD
Bicalutamide—Mental disorder—Doxorubicin—sarcoma	0.000464	0.000664	CcSEcCtD
Bicalutamide—Vomiting—Etoposide—sarcoma	0.000462	0.00066	CcSEcCtD
Bicalutamide—Malnutrition—Doxorubicin—sarcoma	0.000461	0.000659	CcSEcCtD
Bicalutamide—Anaemia—Epirubicin—sarcoma	0.000461	0.000659	CcSEcCtD
Bicalutamide—Rash—Etoposide—sarcoma	0.000458	0.000654	CcSEcCtD
Bicalutamide—Dermatitis—Etoposide—sarcoma	0.000457	0.000654	CcSEcCtD
Bicalutamide—Headache—Etoposide—sarcoma	0.000455	0.00065	CcSEcCtD
Bicalutamide—Flatulence—Doxorubicin—sarcoma	0.000455	0.00065	CcSEcCtD
Bicalutamide—Tension—Doxorubicin—sarcoma	0.000453	0.000647	CcSEcCtD
Bicalutamide—Nervousness—Doxorubicin—sarcoma	0.000448	0.00064	CcSEcCtD
Bicalutamide—Syncope—Epirubicin—sarcoma	0.000447	0.000639	CcSEcCtD
Bicalutamide—Back pain—Doxorubicin—sarcoma	0.000446	0.000638	CcSEcCtD
Bicalutamide—Muscle spasms—Doxorubicin—sarcoma	0.000444	0.000634	CcSEcCtD
Bicalutamide—Loss of consciousness—Epirubicin—sarcoma	0.000438	0.000626	CcSEcCtD
Bicalutamide—Cough—Epirubicin—sarcoma	0.000435	0.000622	CcSEcCtD
Bicalutamide—Nausea—Etoposide—sarcoma	0.000431	0.000616	CcSEcCtD
Bicalutamide—Hypertension—Epirubicin—sarcoma	0.000431	0.000615	CcSEcCtD
Bicalutamide—Anaemia—Doxorubicin—sarcoma	0.000427	0.000609	CcSEcCtD
Bicalutamide—Chest pain—Epirubicin—sarcoma	0.000425	0.000607	CcSEcCtD
Bicalutamide—Myalgia—Epirubicin—sarcoma	0.000425	0.000607	CcSEcCtD
Bicalutamide—Anxiety—Epirubicin—sarcoma	0.000423	0.000605	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000422	0.000603	CcSEcCtD
Bicalutamide—Dry mouth—Epirubicin—sarcoma	0.000415	0.000593	CcSEcCtD
Bicalutamide—Syncope—Doxorubicin—sarcoma	0.000414	0.000591	CcSEcCtD
Bicalutamide—CYP2D6—testis—sarcoma	0.000413	0.0108	CbGeAlD
Bicalutamide—Confusional state—Epirubicin—sarcoma	0.00041	0.000586	CcSEcCtD
Bicalutamide—Oedema—Epirubicin—sarcoma	0.000407	0.000582	CcSEcCtD
Bicalutamide—Loss of consciousness—Doxorubicin—sarcoma	0.000406	0.00058	CcSEcCtD
Bicalutamide—Infection—Epirubicin—sarcoma	0.000404	0.000578	CcSEcCtD
Bicalutamide—Cough—Doxorubicin—sarcoma	0.000403	0.000575	CcSEcCtD
Bicalutamide—Shock—Epirubicin—sarcoma	0.0004	0.000572	CcSEcCtD
Bicalutamide—Nervous system disorder—Epirubicin—sarcoma	0.000399	0.00057	CcSEcCtD
Bicalutamide—Thrombocytopenia—Epirubicin—sarcoma	0.000399	0.000569	CcSEcCtD
Bicalutamide—Hypertension—Doxorubicin—sarcoma	0.000398	0.000569	CcSEcCtD
Bicalutamide—CYP3A4—liver—sarcoma	0.000397	0.0103	CbGeAlD
Bicalutamide—Skin disorder—Epirubicin—sarcoma	0.000395	0.000565	CcSEcCtD
Bicalutamide—Hyperhidrosis—Epirubicin—sarcoma	0.000393	0.000562	CcSEcCtD
Bicalutamide—Myalgia—Doxorubicin—sarcoma	0.000393	0.000561	CcSEcCtD
Bicalutamide—Chest pain—Doxorubicin—sarcoma	0.000393	0.000561	CcSEcCtD
Bicalutamide—Anxiety—Doxorubicin—sarcoma	0.000392	0.000559	CcSEcCtD
Bicalutamide—CYP2D6—liver—sarcoma	0.000391	0.0102	CbGeAlD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00039	0.000557	CcSEcCtD
Bicalutamide—Anorexia—Epirubicin—sarcoma	0.000388	0.000554	CcSEcCtD
Bicalutamide—Dry mouth—Doxorubicin—sarcoma	0.000384	0.000549	CcSEcCtD
Bicalutamide—Confusional state—Doxorubicin—sarcoma	0.00038	0.000543	CcSEcCtD
Bicalutamide—Oedema—Doxorubicin—sarcoma	0.000377	0.000538	CcSEcCtD
Bicalutamide—Infection—Doxorubicin—sarcoma	0.000374	0.000535	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000371	0.00053	CcSEcCtD
Bicalutamide—Shock—Doxorubicin—sarcoma	0.000371	0.000529	CcSEcCtD
Bicalutamide—Nervous system disorder—Doxorubicin—sarcoma	0.000369	0.000528	CcSEcCtD
Bicalutamide—Thrombocytopenia—Doxorubicin—sarcoma	0.000369	0.000527	CcSEcCtD
Bicalutamide—Insomnia—Epirubicin—sarcoma	0.000368	0.000526	CcSEcCtD
Bicalutamide—Skin disorder—Doxorubicin—sarcoma	0.000366	0.000523	CcSEcCtD
Bicalutamide—Paraesthesia—Epirubicin—sarcoma	0.000365	0.000522	CcSEcCtD
Bicalutamide—Hyperhidrosis—Doxorubicin—sarcoma	0.000364	0.00052	CcSEcCtD
Bicalutamide—Dyspnoea—Epirubicin—sarcoma	0.000363	0.000519	CcSEcCtD
Bicalutamide—Somnolence—Epirubicin—sarcoma	0.000362	0.000517	CcSEcCtD
Bicalutamide—Anorexia—Doxorubicin—sarcoma	0.000359	0.000513	CcSEcCtD
Bicalutamide—Dyspepsia—Epirubicin—sarcoma	0.000358	0.000512	CcSEcCtD
Bicalutamide—Decreased appetite—Epirubicin—sarcoma	0.000354	0.000506	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000351	0.000502	CcSEcCtD
Bicalutamide—Fatigue—Epirubicin—sarcoma	0.000351	0.000501	CcSEcCtD
Bicalutamide—Constipation—Epirubicin—sarcoma	0.000348	0.000497	CcSEcCtD
Bicalutamide—Pain—Epirubicin—sarcoma	0.000348	0.000497	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000343	0.00049	CcSEcCtD
Bicalutamide—Insomnia—Doxorubicin—sarcoma	0.000341	0.000487	CcSEcCtD
Bicalutamide—Paraesthesia—Doxorubicin—sarcoma	0.000338	0.000483	CcSEcCtD
Bicalutamide—Dyspnoea—Doxorubicin—sarcoma	0.000336	0.00048	CcSEcCtD
Bicalutamide—Feeling abnormal—Epirubicin—sarcoma	0.000335	0.000479	CcSEcCtD
Bicalutamide—Somnolence—Doxorubicin—sarcoma	0.000335	0.000478	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Epirubicin—sarcoma	0.000333	0.000476	CcSEcCtD
Bicalutamide—Dyspepsia—Doxorubicin—sarcoma	0.000332	0.000474	CcSEcCtD
Bicalutamide—Decreased appetite—Doxorubicin—sarcoma	0.000327	0.000468	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000325	0.000465	CcSEcCtD
Bicalutamide—Fatigue—Doxorubicin—sarcoma	0.000325	0.000464	CcSEcCtD
Bicalutamide—Urticaria—Epirubicin—sarcoma	0.000323	0.000462	CcSEcCtD
Bicalutamide—Constipation—Doxorubicin—sarcoma	0.000322	0.00046	CcSEcCtD
Bicalutamide—Pain—Doxorubicin—sarcoma	0.000322	0.00046	CcSEcCtD
Bicalutamide—Abdominal pain—Epirubicin—sarcoma	0.000322	0.00046	CcSEcCtD
Bicalutamide—Body temperature increased—Epirubicin—sarcoma	0.000322	0.00046	CcSEcCtD
Bicalutamide—Feeling abnormal—Doxorubicin—sarcoma	0.00031	0.000443	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000308	0.00044	CcSEcCtD
Bicalutamide—Hypersensitivity—Epirubicin—sarcoma	0.0003	0.000428	CcSEcCtD
Bicalutamide—Urticaria—Doxorubicin—sarcoma	0.000299	0.000428	CcSEcCtD
Bicalutamide—Body temperature increased—Doxorubicin—sarcoma	0.000298	0.000425	CcSEcCtD
Bicalutamide—Abdominal pain—Doxorubicin—sarcoma	0.000298	0.000425	CcSEcCtD
Bicalutamide—Asthenia—Epirubicin—sarcoma	0.000292	0.000417	CcSEcCtD
Bicalutamide—Pruritus—Epirubicin—sarcoma	0.000288	0.000411	CcSEcCtD
Bicalutamide—Diarrhoea—Epirubicin—sarcoma	0.000278	0.000398	CcSEcCtD
Bicalutamide—Hypersensitivity—Doxorubicin—sarcoma	0.000277	0.000396	CcSEcCtD
Bicalutamide—Asthenia—Doxorubicin—sarcoma	0.00027	0.000386	CcSEcCtD
Bicalutamide—Dizziness—Epirubicin—sarcoma	0.000269	0.000385	CcSEcCtD
Bicalutamide—Pruritus—Doxorubicin—sarcoma	0.000266	0.000381	CcSEcCtD
Bicalutamide—Vomiting—Epirubicin—sarcoma	0.000259	0.00037	CcSEcCtD
Bicalutamide—Diarrhoea—Doxorubicin—sarcoma	0.000258	0.000368	CcSEcCtD
Bicalutamide—Rash—Epirubicin—sarcoma	0.000257	0.000367	CcSEcCtD
Bicalutamide—Dermatitis—Epirubicin—sarcoma	0.000256	0.000366	CcSEcCtD
Bicalutamide—Headache—Epirubicin—sarcoma	0.000255	0.000364	CcSEcCtD
Bicalutamide—Dizziness—Doxorubicin—sarcoma	0.000249	0.000356	CcSEcCtD
Bicalutamide—Nausea—Epirubicin—sarcoma	0.000242	0.000345	CcSEcCtD
Bicalutamide—Vomiting—Doxorubicin—sarcoma	0.000239	0.000342	CcSEcCtD
Bicalutamide—Rash—Doxorubicin—sarcoma	0.000237	0.000339	CcSEcCtD
Bicalutamide—Dermatitis—Doxorubicin—sarcoma	0.000237	0.000339	CcSEcCtD
Bicalutamide—Headache—Doxorubicin—sarcoma	0.000236	0.000337	CcSEcCtD
Bicalutamide—Nausea—Doxorubicin—sarcoma	0.000224	0.00032	CcSEcCtD
